Nuria Perretta Tejedor-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Cardiotrophin-1 therapy reduces disease severity in a murine model of glomerular disease

    Physiological Reports, Vol. 12, Núm. 13

2020

  1. Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

2018

  1. Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific reports

2017

  1. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7

2016

  1. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro

    Cellular Signalling, Vol. 28, Núm. 9, pp. 1252-1261

2014

  1. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1843, Núm. 6, pp. 1111-1122

  2. Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: A case-control study protocol (LOD- Hipertensión)

    BMJ Open, Vol. 4, Núm. 4